Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway

BACKGROUND: Nonalcoholic fatty liver disease is one of the most common liver diseases in the world and is a typical hepatic manifestation of metabolic syndrome which is characterized with lipid accumulation in liver. Nicotinamide phosphoribosyltransferase (NAMPT) has been recently identified as an e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ling-Fang, Wang, Xiao-Nv, Huang, Cong-Cong, Hu, Long, Xiao, Yun-Fei, Guan, Xiao-Hui, Qian, Yi-Song, Deng, Ke-Yu, Xin, Hong-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408374/
https://www.ncbi.nlm.nih.gov/pubmed/28449683
http://dx.doi.org/10.1186/s12944-017-0464-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408374/
https://www.ncbi.nlm.nih.gov/pubmed/28449683
http://dx.doi.org/10.1186/s12944-017-0464-z

Ejemplares similares